ATE203016T1 - Cryptophycine - Google Patents

Cryptophycine

Info

Publication number
ATE203016T1
ATE203016T1 AT95906059T AT95906059T ATE203016T1 AT E203016 T1 ATE203016 T1 AT E203016T1 AT 95906059 T AT95906059 T AT 95906059T AT 95906059 T AT95906059 T AT 95906059T AT E203016 T1 ATE203016 T1 AT E203016T1
Authority
AT
Austria
Prior art keywords
cryptophycins
methods
pharmaceuticals
proliferation
inhibit
Prior art date
Application number
AT95906059T
Other languages
English (en)
Inventor
Richard E Moore
Charles D Smith
Gregory M L Patterson
Susan L Mooberry
Thomas H Corbett
Frederick A Valeriote
Trimurtulu Golakoti
Original Assignee
Univ Hawaii
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Hawaii, Univ Wayne State filed Critical Univ Hawaii
Application granted granted Critical
Publication of ATE203016T1 publication Critical patent/ATE203016T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95906059T 1993-12-21 1994-12-21 Cryptophycine ATE203016T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17263293A 1993-12-21 1993-12-21
US24995594A 1994-05-27 1994-05-27
PCT/US1994/014740 WO1995017093A1 (en) 1993-12-21 1994-12-21 New cryptophycins

Publications (1)

Publication Number Publication Date
ATE203016T1 true ATE203016T1 (de) 2001-07-15

Family

ID=26868303

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95906059T ATE203016T1 (de) 1993-12-21 1994-12-21 Cryptophycine

Country Status (8)

Country Link
US (2) US6013626A (de)
EP (1) EP0735819B1 (de)
JP (1) JPH09510436A (de)
AT (1) ATE203016T1 (de)
AU (1) AU695873B2 (de)
CA (1) CA2179490A1 (de)
DE (1) DE69427706T2 (de)
WO (1) WO1995017093A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09510436A (ja) * 1993-12-21 1997-10-21 ユニバーシティー オブ ハワイ 新規なクリプトフィシン類
AP737A (en) * 1995-03-07 1999-03-15 Univ Hawaii New cryptophycins from synthesis.
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
EP0869786B1 (de) * 1995-12-22 2003-03-05 Eli Lilly And Company Arzneistoffe
ATE201018T1 (de) * 1996-02-27 2001-05-15 Lilly Co Eli Cryptophycinderivate und ihre verwendung als antimikrotubuli mittel
AU722492B2 (en) * 1996-08-30 2000-08-03 University Of Hawaii Pharmaceutical compounds
US5977387A (en) * 1996-08-30 1999-11-02 Eli Lilly And Company Process for preparing pharmaceutical compounds
US6680311B1 (en) 1996-08-30 2004-01-20 Eli Lilly And Company Cryptophycin compounds
EP0957912A1 (de) * 1996-08-30 1999-11-24 Eli Lilly And Company Pharmazeutische zusammensetzungen
HUP0000291A3 (en) * 1996-09-06 2000-10-30 Lilly Co Eli Process to prepare cryptophycin compounds
HUP0000212A3 (en) * 1996-09-06 2001-12-28 Wayne State University Detroit Process to prepare cryptophycin derivatives and intermediates thereof
EP0929535A4 (de) * 1996-09-06 2001-05-23 Lilly Co Eli Verfahren und neue zwischenprodukte
JP2002512603A (ja) * 1997-02-26 2002-04-23 イーライ・リリー・アンド・カンパニー 医薬化合物の製造方法
US6180679B1 (en) * 1998-04-07 2001-01-30 Eli Lilly And Company Method for treating fungal infections
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
US6376230B1 (en) 1998-10-16 2002-04-23 Eli Lilly And Company Stereoselective process for producing intermediates of cryptophycins
IT1307320B1 (it) * 1999-06-29 2001-10-30 Univ Firenze Ceppo cianobatterico del genere nostoc, nonche' colture, biomasse,estratti, molocole bioattive derivate da tale ceppo e loro uso in
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6747021B2 (en) 2000-10-02 2004-06-08 Eli Lilly And Company Cryptophycin compound
WO2002056872A2 (en) * 2000-10-31 2002-07-25 Chemgenex Therapeutics, Inc. Antiproliferative colchicine compositions and uses thereof
US20050170015A1 (en) * 2000-10-31 2005-08-04 Brown Dennis M. Antiproliferative colchicine compositions and uses thereof
US6743598B2 (en) * 2001-08-10 2004-06-01 Mycologics, Inc. Methods for the identification of fungal glucose utilization inhibitors and antifungal agents
CA2556550A1 (en) * 2004-02-17 2005-09-01 University Of South Florida Cytotoxin compound and method of isolation
WO2005116200A2 (en) 2004-05-05 2005-12-08 Regents Of The University Of Minnesota Nucleic acids and polypeptides involved in the production of cryptophycin
US7566558B2 (en) * 2006-07-28 2009-07-28 Regents Of The University Of Michigan Nucleic acids and polypeptides involved in the production of cryptophycin
JP5053444B2 (ja) * 2009-01-02 2012-10-17 チュン−アン ユニバーシティー インダストリー−アカデミー コーポレーション ファンデーション 環状ペンタデプシペプチドおよびそれを生産するフザリウム属微生物
TWI714661B (zh) * 2015-11-05 2021-01-01 法商賽諾菲公司 新穎念珠藻素化合物及接合物、其製備與其治療用途
WO2017141253A1 (en) * 2016-02-16 2017-08-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Non-protein phenylalanine analogues for inhibiting cyanobacteria and plant growth
TN2019000303A1 (en) 2017-05-10 2021-05-07 Sanofi Sa Peptidic linkers and cryptophycin conjugates, useful in therapy, and their preparation
US11530204B2 (en) 2019-09-30 2022-12-20 The Regents Of The University Of Michigan Biocatalytic synthesis of cryptophycin anticancer agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946835A (en) * 1988-07-15 1990-08-07 Merck & Co., Inc. Antifungal fermentation product and method
US4868208A (en) * 1988-07-15 1989-09-19 Merck & Co., Inc. Antifungal agent and method
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
JPH09510436A (ja) * 1993-12-21 1997-10-21 ユニバーシティー オブ ハワイ 新規なクリプトフィシン類

Also Published As

Publication number Publication date
US6013626A (en) 2000-01-11
CA2179490A1 (en) 1995-06-29
US5945315A (en) 1999-08-31
JPH09510436A (ja) 1997-10-21
AU695873B2 (en) 1998-08-27
DE69427706T2 (de) 2001-10-25
WO1995017093A1 (en) 1995-06-29
EP0735819A4 (de) 1997-03-19
EP0735819B1 (de) 2001-07-11
DE69427706D1 (en) 2001-08-16
EP0735819A1 (de) 1996-10-09
AU1442395A (en) 1995-07-10

Similar Documents

Publication Publication Date Title
ATE203016T1 (de) Cryptophycine
ZA9710796B (en) Oxyiminopregnanecarbolactones.
RU94036748A (ru) Церамиды, способ их получения, композиция на их основе и способ гидратирующей обработки кожи или волос
NZ333373A (en) Use of amino acid derivatives for preparing compositions with improved multi-drug resistance activity
GB9514473D0 (en) Chemical compounds
RU95114376A (ru) Нитроэфиры, обладающие фармакологической активностью, и способ их получения
ATE254443T1 (de) Inhibitierung des haarwuchses
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
MX9804221A (es) Reduccion del crecimiento del vello.
ATE172634T1 (de) Hemmen von haarwuchs
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
DE68902916D1 (de) Herstellung von quecksilberfreiem synthesegas, reduktionsgas oder brenngas.
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
IT1285770B1 (it) Composti corticoidei
SE9802206D0 (sv) Novel compounds
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
DE3376524D1 (en) Skin treatment composition
BG104232A (bg) Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
SE9504662D0 (sv) New compounds
BR0211778A (pt) Método para reduzir o crescimento capilar humano, composição para a aplicação tópica à pele, uso de uréia, e, método para produzir uma composição para inibir o crescimento capilar de mamìfero
TR199701298T1 (xx) Tetralinler.
TR199800210T2 (xx) Didepsipeptid temelli endoparazitisid kompozisyonlar, yeni didepsipeptidler ve bunlar�n �retimi i�in i�lemler.
DK7286A (da) Octahydroindoliziner
NO870423L (no) 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter.
PT740657E (pt) 4-aril-isoindois com actividade analgesica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee